Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate

Journal of Clinical Psychopharmacology

Volumn 28, Issue 5, 2008, Pages 555-560

  Langosch, Jens M ^a   Drieling, Tobias ^a   Biedermann, Nane C ^a   Born, Christoph ^b   Sasse, Johanna ^c   Bauer, Hartmut ^d   Walden, Joerg ^e   Bauer, Michael ^c   Grunze, Heinz ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d ASTRAZENECA   (United Kingdom)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; HALOPERIDOL; HYPNOTIC AGENT; PAROXETINE; QUETIAPINE; VALPROIC ACID; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ACCOMODATION DISORDER; ADULT; AGED; ARTICLE; ATOPY; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; EDEMA; FATIGUE; FEMALE; GERMANY; HAMILTON SCALE; HEADACHE; HEART PALPITATION; HUMAN; INFLUENZA; MALE; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; OPEN STUDY; ORTHOSTATIC HYPOTENSION; PARALLEL DESIGN; PARESTHESIA; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAPID CYCLING BIPOLAR DISORDER; RESTLESSNESS; SEDATION; SIDE EFFECT; SOMNOLENCE; STOMACH SPASM; TREATMENT DURATION; UROGENITAL TRACT INFECTION; VISUAL DISORDER; VOMITING; WEIGHT GAIN; XEROSTOMIA; YOUNG MANIA RATING SCALE; BIPOLAR DISORDER; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; TREATMENT OUTCOME;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; FEMALE; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VALPROIC ACID; WEIGHT GAIN;

EID: 58149123725     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318185e75f     Document Type: Article

References (26)

1. Bauer M, Beaulieu S, Dunner D, et al. Rapid cycling bipolar disorder-diagnostic concepts. Bipolar Disord. 2008;10:153-162.
2. Kupka RW, Luckenbaugh DA, Post RM, et al. Comparison of rapid- cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry. 2005;162:1273-1280.
3. Schneck CD. Treatment of rapid-cycling bipolar disorder. J Clin Psychiatry. 2006;67:22-27.
4. Tondo L, Hennen J, Baldessarini RJ. Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand. 2003;108:4-14.
5. Yatham LN, Kennedy SH, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord. 2006;8:721-739.
6. Ozcan ME, Shivakumar G, Suppes T. Treating rapid cycling bipolar disorder with novel medications. Curr Psychiatry Rev. 2006;2:361-369.
7. Vieta E, Parramon G, Padrell E, et al. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord. 2002;4:335-340.
8. Thase ME, Macfadden W, Weisler RH, et al. efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo- controlled study (the BOLDER II study). J Clin Psychopharmacol. 2006;26:600-609.
9. Bowden CL, Grunze H, Mullen J, et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry. 2005; 66:111-121.
10. Calabrese JR, Keck PE Jr, Macfadden W, et al. A randomized, doubleblind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. 2005;162:1351-1360.
11. Vieta E, Eggens I, Persson I, et al. efficacy and safety of quetiapine in combination with lithium/divalproex as maintenance treatment for bipolar I disorder. Eur Neuropsychopharmacol. 2007;17:S457.
12. Goldberg JF, Kelley ME, Rosenquist KJ, et al. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study. J Affect Disord. 2008;105:305-310.
13. Goldstein JM, Christoph G, Grimm S, et al. Unique mechanism of action for the antidepressant properties of the atypical antipsychotic quetiapine. Biol Psychiatry. 2007;61:125S.
14. Yatham LN, Goldstein JM, Vieta E, et al. Atypical antipsychotics in bipolar depression: potential mechanisms of action. J Clin Psychiatry. 2005;66(suppl 5):40-48.
15. Spearing MK, Post RM, Leverich GS, et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73:159-171.
16. Denicoff KD, Leverich GS, Nolen WA, et al. Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med. 2000;30:1391-1397.
17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
18. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
19. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429-435.
20. Janno S, Holi MM, Tuisku K, et al. Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population. BMC Neurol. 2005;5:5.
21. Altamura AC, Salvadori D, Madaro D, et al. efficacy and tolera- bility of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study. J Affect Disord. 2003;76: 267-271.
22. Hardoy MC, Garofalo A, Carpiniello B, et al. Combination quetiapine therapy in the long-term treatment of patients with bipolar I disorder. Clin Pract Epidemol Ment Health. 2005;1:7.
23. Milev R, Abraham G, Zaheer J. Add-on quetiapine for bipolar depression: a 12-month open-label trial. Can J Psychiatry. 2006;51: 523-530.
24. McIntyre RS, Konarski JZ, Jones M, et al. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. J Affect Disord. 2007;100(suppl 1):S5-14.
25. Vieta E, Calabrese JR, Goikolea JM, et al. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid- cycling disease course: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 2007;9:413-425.
26. Sachse J, Koller J, Hartter S, et al. Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performanceliquid chromatography with column-switching and spectrophotometric detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;830: 342-348.